# Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i

> **NCT00498680** · PHASE4 · UNKNOWN · sponsor: **Rambam Health Care Campus** · enrollment: 46 (estimated)

## Conditions studied

- Impotence

## Interventions

- **DRUG:** Sildenafil, Vardenafil
- **DRUG:** Sildenafil
- **DRUG:** Vardenafil
- **DRUG:** Sildenafil & Vardenafil

## Key facts

- **NCT ID:** NCT00498680
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-03
- **Primary completion:** 2011-01
- **Final completion:** 2011-06
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2010-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00498680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00498680, "Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00498680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*